companydata.dkcompanydata.dk

Octarine Bio ApS: Financial statements 2022

CVR: 39857316

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Octarine Bio ApS (CVR 39857316) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,378,113 and a net result of DKK -9,671,375 compared with DKK -6,418,626 the year before. That is a decrease of 18% compared with the year before. Equity in the 2022 report amounted to DKK -3,144,841. The company had 9 employees in the financial year.

Gross Profit
DKK 1,378,113
Profit/Loss
DKK -9,671,375
Equity
DKK -3,144,841
Total Assets
DKK 15,340,052
Employees
9

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-1.4 mio.-9.7 mio.-3.1 mio.9
2021-1.7 mio.-6.4 mio.6.5 mio.7
2020-917 t.-2.4 mio.-900 t.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Octarine Bio ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Lene Gerlach leaves the board of Octarine Bio ApSDec 31, 2022

As of December 31, 2022, Lene Gerlach has left the board of directors of Octarine Bio ApS.

Christian Brix Tillegreen leaves the board of Octarine Bio ApSDec 31, 2022

As of December 31, 2022, Christian Brix Tillegreen has left the board of directors of Octarine Bio ApS.

Nethaji Janeshawari Gallage joins the board of Octarine Bio ApSAug 1, 2022

As of August 1, 2022, Nethaji Janeshawari Gallage has joined the board of directors of Octarine Bio ApS.

Octarine Bio ApS: The 2021 annual report is outJun 21, 2022

Octarine Bio ApS has published its annual report for 2021. Gross profit came to DKK 1,681,548, and the net result was DKK -6,418,626.

About Octarine Bio ApS

Octarine Bio ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Octarine Bio IVS. The management consists of Nethaji Janeshawari Gallage and Nicholas Stuart William Milne. The board consists of Stephan Christgau (chair), Akshat Kshetrapal, Alexandre Ouimet-Storrs and Anna Søndergaard. The company's owners include Nicholas Stuart William Milne, Biosphere ApS and UV Fund I K/S. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 1,715,333 and a net result of DKK -11,501,321 compared with DKK -22,298,751 the year before. Equity in the 2025 report amounted to DKK 31,907,827.

Source: annual report 2025, Danish Business Authority

Other financial years